A Randomized Phase II Study of Docetaxel or Pemetrexed with or Without the Continuation of Gefitinib after Disease Progression in Elderly Patients with Non‐small Cell Lung Cancer Harboring EGFR Mutations (JMTO LC12‐01)
Thoracic cancer（2022）
关键词
chemotherapy,elderly,epidermal growth factor receptor mutation,gefitinib,non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要